Clinical Research on Rare Diseases

Clinical researchers working on rare diseases frequently encounter difficulties unique to the study of uncommon disorders. Rare diseases can offer unique possibilities to examine human physiology and biomedical science. An estimated 25–30 million persons (8–12% of the population) are thought to have one of the roughly 7000 rare diseases that affect this community. The Orphan Drug Act was passed in 1983 with the goal of encouraging the development of medications to treat, prevent, or diagnose uncommon diseases or ailments that afflict fewer than 200,000 people. Over the past two decades, there has been a significant change in both the scientific technique and the logistics of clinical research for rare diseases. The pathogenesis of the disease is now more understood, and numerous innovative treatments have been created.

  • Orphan products clinical Trials Grants Program
  • Rexin G
  • Biomedical

    Related Conference of Clinical Research on Rare Diseases

    September 25-26, 2023

    14th International Conference on Emerging Infectious Diseases

    Zurich, Switzerland
    September 27-28, 2023

    32nd International Conference on Coronary Diseases

    Zurich, Switzerland
    October 04-04, 2023

    6th International Conference on Rare Diseases

    Amsterdam, Netherlands
    October 09-10, 2023

    15th Euro-Global Conference on Infectious Diseases

    Zurich, Switzerland
    October 25-26, 2023

    13th International Conference on GI Disorders

    Nova Scotia, Canada
    December 07-08, 2023

    6th Pathology and Infectious Disease Conference

    Prague, Czech Republic
    February 22-23, 2024

    9th Annual Summit on Rare Diseases and Orphan Drugs

    Zurich, Switzerland
    February 23-24, 2024

    11th International Congress on Infectious Diseases

    Barcelona, Spain

    Clinical Research on Rare Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in